BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 14662831)

  • 1. Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection.
    Chamekh M; Vercruysse V; Habib M; Lorent M; Goldman M; Allaoui A; Vray B
    Infect Immun; 2005 Oct; 73(10):6552-61. PubMed ID: 16177330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.
    Planelles L; Thomas MC; Alonso C; López MC
    Infect Immun; 2001 Oct; 69(10):6558-63. PubMed ID: 11553607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
    Spencer AJ; Furze J; Honeycutt JD; Calvert A; Saurya S; Colloca S; Wyllie DH; Gilbert SC; Bregu M; Cottingham MG; Hill AV
    PLoS One; 2014; 9(8):e105520. PubMed ID: 25140889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chagas Disease: A Silent Threat for Dogs and Humans.
    Durães-Oliveira J; Palma-Marques J; Moreno C; Rodrigues A; Monteiro M; Alexandre-Pires G; da Fonseca IP; Santos-Gomes G
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.
    Vellozo NS; Rigoni TS; Lopes MF
    Front Immunol; 2021; 12():704429. PubMed ID: 34249011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of T cell-associated tissues and T cell activation by RANKL-RANK-OPG.
    Walsh MC; Choi Y
    J Bone Miner Metab; 2021 Jan; 39(1):54-63. PubMed ID: 33438173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANK Ligand Helps Immunity to
    Rigoni TS; Vellozo NS; Cabral-Piccin M; Fabiano-Coelho L; Lopes UG; Filardy AA; DosReis GA; Lopes MF
    Front Immunol; 2020; 11():886. PubMed ID: 32477357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-RANKing the Threat of HSV-1: RANKL Upregulates MHC-Class-I-Restricted Anti-Viral Immunity in Herpes Simplex Virus Infection.
    Finsterbusch K; Piguet V
    J Invest Dermatol; 2015 Nov; 135(11):2565-2567. PubMed ID: 26548487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.
    Klenner L; Hafezi W; Clausen BE; Lorentzen EU; Luger TA; Beissert S; Kühn JE; Loser K
    J Invest Dermatol; 2015 Nov; 135(11):2676-2687. PubMed ID: 26076314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?
    Dos Santos Virgilio F; Pontes C; Dominguez MR; Ersching J; Rodrigues MM; Vasconcelos JR
    Mediators Inflamm; 2014; 2014():243786. PubMed ID: 25104879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
    Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
    J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.
    Takayama E; Ono T; Carnero E; Umemoto S; Yamaguchi Y; Kanayama A; Oguma T; Takashima Y; Tadakuma T; García-Sastre A; Miyahira Y
    Int J Parasitol; 2010 Nov; 40(13):1549-61. PubMed ID: 20620143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD40 and CD154/CD40L in dendritic cells.
    Ma DY; Clark EA
    Semin Immunol; 2009 Oct; 21(5):265-72. PubMed ID: 19524453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
    Stone GW; Barzee S; Snarsky V; Kee K; Spina CA; Yu XF; Kornbluth RS
    J Virol; 2006 Feb; 80(4):1762-72. PubMed ID: 16439533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: a potent adjuvant effect of ligand to receptor activator of NF-kappa B gene for inducing antigen-specific CD8+ T cell response by DNA and viral vector vaccination.
    Miyahira Y; Akiba H; Katae M; Kubota K; Kobayashi S; Takeuchi T; García-Sastre A; Fukuchi Y; Okumura K; Yagita H; Aoki T
    J Immunol; 2003 Dec; 171(12):6344-8. PubMed ID: 14662831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.
    Miyahira Y; Takashima Y; Kobayashi S; Matsumoto Y; Takeuchi T; Ohyanagi-Hara M; Yoshida A; Ohwada A; Akiba H; Yagita H; Okumura K; Ogawa H
    Infect Immun; 2005 Nov; 73(11):7356-65. PubMed ID: 16239534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.